AstraZeneca
AZN
#49
Rank
HK$2.247 T
Marketcap
HK$724.78
Share price
0.19%
Change (1 day)
33.36%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: HK$2.247 Trillion

As of January 2026 AstraZeneca has a market cap of HK$2.247 Trillion. This makes AstraZeneca the world's 49th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$2.247 T0.27%
2025HK$2.241 T40.51%
2024HK$1.594 T-2.18%
2023HK$1.630 T-0.81%
2022HK$1.643 T16.17%
2021HK$1.415 T39.35%
2020HK$1.015 T-0.37%
2019HK$1.019 T37.85%
2018HK$739.41 B8.62%
2017HK$680.71 B27.29%
2016HK$534.78 B-20.19%
2015HK$670.10 B-3.54%
2014HK$694.68 B20.9%
2013HK$574.61 B26.46%
2012HK$454.37 B-2.21%
2011HK$464.64 B-8.26%
2010HK$506.48 B-4.09%
2009HK$528.08 B15.07%
2008HK$458.93 B-5.65%
2007HK$486.44 B-23.76%
2006HK$638.02 B5.43%
2005HK$605.16 B30.17%
2004HK$464.91 B-26.77%
2003HK$634.88 B34.99%
2002HK$470.31 B-25.84%
2001HK$634.19 B-10.59%
2000HK$709.33 B23.14%
1999HK$576.03 B74.43%
1998HK$330.24 B24.73%
1997HK$264.77 B29.07%
1996HK$205.14 B

End of Day market cap according to different sources

On Jan 30th, 2026 the market cap of AstraZeneca was reported to be:

HK$2.247 Trillion
by Nasdaq info icon info icon
HK$2.247 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.277 T 90.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.228 T-0.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$1.174 T-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.486 T-33.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.263 T 223.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$892.64 B-60.28%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$206.17 B-90.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.151 T-4.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$875.55 B-61.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$814.75 B-63.74%๐Ÿ‡ฌ๐Ÿ‡ง UK